“There has been much confusion and sensational headlines about the role of different types of fat in CHD,” said Frank Hu, senior author and professor of nutrition and epidemiology at Harvard School of Public Health. “Randomized clinical trials have shown that replacing saturated fat with polyunsaturated fat reduces total and LDL cholesterol. And our comprehensive meta-analysis provides clear evidence to support the benefits of consuming polyunsaturated fat as a replacement for saturated fat.”
The study appears in the October 28, 2014 print issue of Circulation.
The researchers performed a systematic review and meta-analysis of prospective cohort studies to summarize the evidence regarding the link between dietary linoleic acid intake and CHD risk in generally healthy people. They identified 13 published and unpublished cohort studies with a total of 310,602 individuals and 12,479 total CHD events including 5,882 CHD deaths.
Results showed that dietary linoleic acid intake is inversely associated with CHD risk in a dose-response manner—meaning, higher intake of linoleic acid resulted in a lower risk of CHD. Comparing the highest to the lowest level of consumption, dietary linoleic acid was associated with a 15% lower risk of CHD events and a 21% lower risk of CHD deaths. These results were independent of common coronary heart disease risk factors such as smoking and other dietary factors such as fiber consumption.
In practice, say the authors, these findings support replacing butter, lard, and fat from red meat with liquid plant oils in cooking and at the table. Although not addressed in this analysis, trans fat from partially hydrogenated vegetable oils should be avoided, they add.
Lead author of the study was Maryam Farvid, a visiting scientist in the Department of Nutrition at HSPH.
Watch a video of an event held at HSPH in May 2014: Saturated or not: Does type of fat matter?
This study was supported by National Institutes of Health grants HL60712, UM1 CA167552, and P01 CA055075.
“Dietary Linoleic Acid and Risk of Coronary Heart Disease: A Systematic Review and Meta-Analysis of Prospective Cohort Studies,” Maryam S. Farvid, An Pan, Qi Sun, Stephanie E. Chiuve, Lyn M. Steffen, Walter C. Willett, Frank B. Hu, Circulation, October 28, 2014, DOI: 10.1161.
For more information:
Harvard School of Public Health brings together dedicated experts from many disciplines to educate new generations of global health leaders and produce powerful ideas that improve the lives and health of people everywhere. As a community of leading scientists, educators, and students, we work together to take innovative ideas from the laboratory to people’s lives—not only making scientific breakthroughs, but also working to change individual behaviors, public policies, and health care practices. Each year, more than 400 faculty members at HSPH teach 1,000-plus full-time students from around the world and train thousands more through online and executive education courses. Founded in 1913 as the Harvard-MIT School of Health Officers, the School is recognized as America’s oldest professional training program in public health.